

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | sarcomere organization (GO:0045214) | 8.84231541 |
| 2 | cardiac myofibril assembly (GO:0055003) | 8.73313333 |
| 3 | myofibril assembly (GO:0030239) | 7.58524243 |
| 4 | actin-myosin filament sliding (GO:0033275) | 7.25774395 |
| 5 | muscle filament sliding (GO:0030049) | 7.25774395 |
| 6 | * negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 6.97646478 |
| 7 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 6.89165851 |
| 8 | tricarboxylic acid cycle (GO:0006099) | 6.57813706 |
| 9 | * regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 6.52363321 |
| 10 | * negative regulation of potassium ion transmembrane transport (GO:1901380) | 6.37101425 |
| 11 | cardiac muscle cell development (GO:0055013) | 6.36886449 |
| 12 | regulation of relaxation of muscle (GO:1901077) | 6.36785458 |
| 13 | regulation of sarcomere organization (GO:0060297) | 6.29717510 |
| 14 | * regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 6.29133832 |
| 15 | * cardiac muscle contraction (GO:0060048) | 6.28141746 |
| 16 | regulation of actin filament-based movement (GO:1903115) | 6.19106250 |
| 17 | actin-mediated cell contraction (GO:0070252) | 6.06092247 |
| 18 | plasma membrane repair (GO:0001778) | 6.02748946 |
| 19 | cardiac cell development (GO:0055006) | 5.97799132 |
| 20 | ventricular cardiac muscle cell action potential (GO:0086005) | 5.93683548 |
| 21 | * regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 5.68644945 |
| 22 | cardiac muscle hypertrophy (GO:0003300) | 5.68031088 |
| 23 | actomyosin structure organization (GO:0031032) | 5.66768735 |
| 24 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 5.65896221 |
| 25 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 5.63476499 |
| 26 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 5.56133262 |
| 27 | regulation of skeletal muscle contraction (GO:0014819) | 5.53798848 |
| 28 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 5.53143931 |
| 29 | cardiac muscle tissue morphogenesis (GO:0055008) | 5.48754386 |
| 30 | ventricular cardiac muscle tissue morphogenesis (GO:0055010) | 5.39850226 |
| 31 | heart trabecula formation (GO:0060347) | 5.38266939 |
| 32 | striated muscle hypertrophy (GO:0014897) | 5.37716165 |
| 33 | adult heart development (GO:0007512) | 5.19619872 |
| 34 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 5.18809641 |
| 35 | * striated muscle contraction (GO:0006941) | 5.09744424 |
| 36 | carnitine shuttle (GO:0006853) | 5.09090128 |
| 37 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 5.06419463 |
| 38 | muscle tissue morphogenesis (GO:0060415) | 4.92127202 |
| 39 | * regulation of striated muscle contraction (GO:0006942) | 4.86850212 |
| 40 | * regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 4.81009700 |
| 41 | regulation of the force of heart contraction (GO:0002026) | 4.76901600 |
| 42 | muscle hypertrophy (GO:0014896) | 4.75550539 |
| 43 | heart process (GO:0003015) | 4.69182293 |
| 44 | heart contraction (GO:0060047) | 4.69182293 |
| 45 | regulation of coenzyme metabolic process (GO:0051196) | 4.61700252 |
| 46 | regulation of cofactor metabolic process (GO:0051193) | 4.61700252 |
| 47 | actin filament-based movement (GO:0030048) | 4.57153905 |
| 48 | regulation of cardiac muscle cell contraction (GO:0086004) | 4.55526507 |
| 49 | fatty acid transmembrane transport (GO:1902001) | 4.52189151 |
| 50 | cell communication by electrical coupling (GO:0010644) | 4.50484316 |
| 51 | relaxation of cardiac muscle (GO:0055119) | 4.47013887 |
| 52 | response to muscle activity (GO:0014850) | 4.34275839 |
| 53 | * cell communication involved in cardiac conduction (GO:0086065) | 4.31846587 |
| 54 | neurological system process involved in regulation of systemic arterial blood pressure (GO:0001976) | 4.28615100 |
| 55 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 4.22941065 |
| 56 | cardiac muscle cell action potential (GO:0086001) | 4.22829659 |
| 57 | cardiac muscle cell action potential involved in contraction (GO:0086002) | 4.22711206 |
| 58 | * regulation of membrane repolarization (GO:0060306) | 4.19935820 |
| 59 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 4.14721184 |
| 60 | cardiac muscle hypertrophy in response to stress (GO:0014898) | 4.13980339 |
| 61 | muscle hypertrophy in response to stress (GO:0003299) | 4.13980339 |
| 62 | cardiac muscle adaptation (GO:0014887) | 4.13980339 |
| 63 | * regulation of cardiac muscle contraction (GO:0055117) | 4.08573111 |
| 64 | negative regulation of protein localization to cell surface (GO:2000009) | 4.08193664 |
| 65 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 4.07648195 |
| 66 | regulation of cardioblast differentiation (GO:0051890) | 4.05442555 |
| 67 | negative regulation of cardiac muscle cell apoptotic process (GO:0010667) | 3.92395373 |
| 68 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 3.91522998 |
| 69 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.90662208 |
| 70 | ATP synthesis coupled proton transport (GO:0015986) | 3.90662208 |
| 71 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.90134319 |
| 72 | cellular response to epinephrine stimulus (GO:0071872) | 3.89361430 |
| 73 | * regulation of heart rate (GO:0002027) | 3.89114108 |
| 74 | ventricular cardiac muscle cell development (GO:0055015) | 3.86466415 |
| 75 | cardiac conduction (GO:0061337) | 3.83429867 |
| 76 | response to epinephrine (GO:0071871) | 3.83037976 |
| 77 | regulation of sulfur metabolic process (GO:0042762) | 3.82306871 |
| 78 | respiratory electron transport chain (GO:0022904) | 3.82059648 |
| 79 | striated muscle cell development (GO:0055002) | 3.81853170 |
| 80 | cardiac ventricle formation (GO:0003211) | 3.81611883 |
| 81 | * regulation of muscle contraction (GO:0006937) | 3.78467930 |
| 82 | regulation of ATPase activity (GO:0043462) | 3.77467575 |
| 83 | regulation of ATP catabolic process (GO:1903289) | 3.77467575 |
| 84 | carnitine transmembrane transport (GO:1902603) | 3.76004801 |
| 85 | skeletal muscle contraction (GO:0003009) | 3.75461588 |
| 86 | oxidative phosphorylation (GO:0006119) | 3.73932310 |
| 87 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.72732473 |
| 88 | muscle cell cellular homeostasis (GO:0046716) | 3.71496235 |
| 89 | electron transport chain (GO:0022900) | 3.70016429 |
| 90 | * regulation of muscle system process (GO:0090257) | 3.68108863 |
| 91 | 2-oxoglutarate metabolic process (GO:0006103) | 3.65371235 |
| 92 | * regulation of cell communication by electrical coupling (GO:0010649) | 3.64128281 |
| 93 | * regulation of heart contraction (GO:0008016) | 3.61410617 |
| 94 | striated muscle atrophy (GO:0014891) | 3.60310513 |
| 95 | NADH metabolic process (GO:0006734) | 3.56122124 |
| 96 | * muscle contraction (GO:0006936) | 3.55010793 |
| 97 | * regulation of calcium ion transmembrane transporter activity (GO:1901019) | 3.51753233 |
| 98 | * regulation of calcium ion transmembrane transport (GO:1903169) | 3.51753233 |
| 99 | creatine metabolic process (GO:0006600) | 3.51456004 |
| 100 | regulation of sequestering of triglyceride (GO:0010889) | 3.50780246 |
| 101 | regulation of heart rate by cardiac conduction (GO:0086091) | 3.50763465 |
| 102 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 3.50427644 |
| 103 | negative regulation of striated muscle cell apoptotic process (GO:0010664) | 3.49691169 |
| 104 | muscle fiber development (GO:0048747) | 3.47978559 |
| 105 | striated muscle adaptation (GO:0014888) | 3.46422829 |
| 106 | trabecula formation (GO:0060343) | 3.46281376 |
| 107 | carnitine transport (GO:0015879) | 3.41496688 |
| 108 | amino-acid betaine transport (GO:0015838) | 3.41496688 |
| 109 | * muscle system process (GO:0003012) | 3.38166932 |
| 110 | positive regulation of action potential (GO:0045760) | 3.36135303 |
| 111 | muscle adaptation (GO:0043500) | 3.36119206 |
| 112 | positive regulation of cation channel activity (GO:2001259) | 3.36051278 |
| 113 | * negative regulation of potassium ion transport (GO:0043267) | 3.34382504 |
| 114 | response to inactivity (GO:0014854) | 3.33315412 |
| 115 | cardiac chamber formation (GO:0003207) | 3.32406194 |
| 116 | positive regulation of heart rate (GO:0010460) | 3.31336668 |
| 117 | adrenergic receptor signaling pathway (GO:0071875) | 3.30175912 |
| 118 | muscle cell development (GO:0055001) | 3.29564006 |
| 119 | positive regulation of heart contraction (GO:0045823) | 3.28872138 |
| 120 | skeletal muscle tissue development (GO:0007519) | 3.25019251 |
| 121 | positive regulation of myoblast differentiation (GO:0045663) | 3.21910036 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 6.33179029 |
| 2 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 5.36913741 |
| 3 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 4.24073860 |
| 4 | * TBX20_22080862_ChIP-Seq_HEART_Mouse | 4.13997012 |
| 5 | * TBX20_22328084_ChIP-Seq_HEART_Mouse | 4.13997012 |
| 6 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 3.92221198 |
| 7 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 3.77942611 |
| 8 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 3.37588519 |
| 9 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 3.32821450 |
| 10 | ZNF263_19887448_ChIP-Seq_K562_Human | 3.05010569 |
| 11 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.70995614 |
| 12 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 2.68562062 |
| 13 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 2.41417465 |
| 14 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 2.28684400 |
| 15 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.25052581 |
| 16 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.08378646 |
| 17 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.96831889 |
| 18 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.90629187 |
| 19 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.90244964 |
| 20 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.87375460 |
| 21 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.86267264 |
| 22 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.86227240 |
| 23 | VDR_22108803_ChIP-Seq_LS180_Human | 1.83391572 |
| 24 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.81750056 |
| 25 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.79191463 |
| 26 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.78595715 |
| 27 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.76719480 |
| 28 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.67944491 |
| 29 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.66946417 |
| 30 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.57094999 |
| 31 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.54068501 |
| 32 | GATA1_22025678_ChIP-Seq_K562_Human | 1.53338606 |
| 33 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.45950311 |
| 34 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.40286601 |
| 35 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.36420687 |
| 36 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.33648814 |
| 37 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.32711543 |
| 38 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.32141527 |
| 39 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.31210193 |
| 40 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.31009408 |
| 41 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.29713683 |
| 42 | * NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.27213695 |
| 43 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.26728624 |
| 44 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 1.24368414 |
| 45 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.23051313 |
| 46 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.21845441 |
| 47 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.21689690 |
| 48 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.21271224 |
| 49 | CJUN_26792858_Chip-Seq_BT549_Human | 1.20320717 |
| 50 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.18703744 |
| 51 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.15395516 |
| 52 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.15288433 |
| 53 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.14631035 |
| 54 | GATA1_19941826_ChIP-Seq_K562_Human | 1.13529793 |
| 55 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.12737297 |
| 56 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.12217632 |
| 57 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.11101825 |
| 58 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.10732319 |
| 59 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.09409424 |
| 60 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.08224732 |
| 61 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.06736937 |
| 62 | * SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.06466086 |
| 63 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.06207999 |
| 64 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.04134077 |
| 65 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.02648895 |
| 66 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.02646900 |
| 67 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.02269729 |
| 68 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.99753834 |
| 69 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 0.95561803 |
| 70 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.94424154 |
| 71 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 0.94331370 |
| 72 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.94009622 |
| 73 | * RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.93397216 |
| 74 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.93041724 |
| 75 | * SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.92967836 |
| 76 | ATF3_27146783_Chip-Seq_COLON_Human | 0.92850673 |
| 77 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.92298965 |
| 78 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.92041082 |
| 79 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.91817997 |
| 80 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.91299846 |
| 81 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.90791470 |
| 82 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 0.90350957 |
| 83 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.89863621 |
| 84 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.89800556 |
| 85 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.89388369 |
| 86 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.88968071 |
| 87 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.88942250 |
| 88 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 0.87838350 |
| 89 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.87836223 |
| 90 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.87322327 |
| 91 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.86793711 |
| 92 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.86793711 |
| 93 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.86669497 |
| 94 | TP53_16413492_ChIP-PET_HCT116_Human | 0.86207324 |
| 95 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 0.86137928 |
| 96 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.85800119 |
| 97 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.85598630 |
| 98 | GF1_26923725_Chip-Seq_HPCs_Mouse | 0.84533790 |
| 99 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.83892324 |
| 100 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.83649364 |
| 101 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.83587995 |
| 102 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.82747368 |
| 103 | GATA2_19941826_ChIP-Seq_K562_Human | 0.82281471 |
| 104 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.81879168 |
| 105 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 0.81742620 |
| 106 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.81513946 |
| 107 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.81032424 |
| 108 | * ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.80886726 |
| 109 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.80568377 |
| 110 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.80323982 |
| 111 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 0.79823089 |
| 112 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.79399111 |
| 113 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.79195155 |
| 114 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.79153556 |
| 115 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.79085209 |
| 116 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 0.78176427 |
| 117 | * SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.77238269 |
| 118 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.77167606 |
| 119 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.76859188 |
| 120 | * SMC3_22415368_ChIP-Seq_MEFs_Mouse | 0.76641412 |
| 121 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.76103603 |
| 122 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.76035102 |
| 123 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.75997735 |
| 124 | * TP53_23651856_ChIP-Seq_MEFs_Mouse | 0.75485943 |
| 125 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 0.75399476 |
| 126 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 0.75399476 |
| 127 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.74653108 |
| 128 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.74549832 |
| 129 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.73265613 |
| 130 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.73243851 |
| 131 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.73019265 |
| 132 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.72914903 |
| 133 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 0.72807964 |
| 134 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.69086914 |
| 135 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.68942497 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002837_dystrophic_cardiac_calcinosis | 6.35446757 |
| 2 | MP0004084_abnormal_cardiac_muscle | 6.13620620 |
| 3 | MP0000751_myopathy | 5.21086324 |
| 4 | MP0003646_muscle_fatigue | 4.87246373 |
| 5 | * MP0004215_abnormal_myocardial_fiber | 4.75471737 |
| 6 | MP0004036_abnormal_muscle_relaxation | 4.33367584 |
| 7 | MP0005330_cardiomyopathy | 4.10456874 |
| 8 | MP0000749_muscle_degeneration | 3.91747547 |
| 9 | * MP0002972_abnormal_cardiac_muscle | 3.17971122 |
| 10 | * MP0004087_abnormal_muscle_fiber | 3.13671330 |
| 11 | MP0008775_abnormal_heart_ventricle | 3.12881392 |
| 12 | MP0003137_abnormal_impulse_conducting | 3.05758286 |
| 13 | MP0000750_abnormal_muscle_regeneration | 2.93378550 |
| 14 | * MP0005620_abnormal_muscle_contractility | 2.71812616 |
| 15 | MP0005385_cardiovascular_system_phenoty | 2.67141632 |
| 16 | MP0001544_abnormal_cardiovascular_syste | 2.67141632 |
| 17 | * MP0010630_abnormal_cardiac_muscle | 2.65624283 |
| 18 | MP0002106_abnormal_muscle_physiology | 2.65387024 |
| 19 | MP0004130_abnormal_muscle_cell | 2.58268381 |
| 20 | MP0006138_congestive_heart_failure | 2.47935847 |
| 21 | MP0003828_pulmonary_edema | 2.45634821 |
| 22 | MP0004145_abnormal_muscle_electrophysio | 2.39898566 |
| 23 | * MP0004484_altered_response_of | 2.30537641 |
| 24 | MP0002269_muscular_atrophy | 2.27081789 |
| 25 | MP0005369_muscle_phenotype | 2.14001791 |
| 26 | * MP0004085_abnormal_heartbeat | 2.10891638 |
| 27 | MP0000747_muscle_weakness | 2.08429377 |
| 28 | MP0004510_myositis | 2.02420498 |
| 29 | MP0000759_abnormal_skeletal_muscle | 2.00153907 |
| 30 | MP0003221_abnormal_cardiomyocyte_apopto | 1.87462208 |
| 31 | MP0003950_abnormal_plasma_membrane | 1.87154691 |
| 32 | MP0004233_abnormal_muscle_weight | 1.76766942 |
| 33 | MP0002127_abnormal_cardiovascular_syste | 1.75017794 |
| 34 | MP0006036_abnormal_mitochondrial_physio | 1.59030646 |
| 35 | MP0003567_abnormal_fetal_cardiomyocyte | 1.50574362 |
| 36 | MP0002332_abnormal_exercise_endurance | 1.37454930 |
| 37 | MP0010368_abnormal_lymphatic_system | 1.28497264 |
| 38 | MP0003279_aneurysm | 1.28480256 |
| 39 | MP0005666_abnormal_adipose_tissue | 1.24825179 |
| 40 | * MP0000266_abnormal_heart_morphology | 1.18379735 |
| 41 | MP0005623_abnormal_meninges_morphology | 1.15228298 |
| 42 | MP0000343_altered_response_to | 1.15037533 |
| 43 | MP0002234_abnormal_pharynx_morphology | 1.09137321 |
| 44 | MP0005670_abnormal_white_adipose | 0.98371499 |
| 45 | MP0000733_abnormal_muscle_development | 0.97970832 |
| 46 | MP0004272_abnormal_basement_membrane | 0.97687682 |
| 47 | MP0001661_extended_life_span | 0.96921662 |
| 48 | MP0002108_abnormal_muscle_morphology | 0.95688217 |
| 49 | MP0006035_abnormal_mitochondrial_morpho | 0.95356650 |
| 50 | * MP0005165_increased_susceptibility_to | 0.93561633 |
| 51 | MP0003566_abnormal_cell_adhesion | 0.91500097 |
| 52 | MP0002128_abnormal_blood_circulation | 0.87158791 |
| 53 | MP0004270_analgesia | 0.85711085 |
| 54 | MP0005375_adipose_tissue_phenotype | 0.85524227 |
| 55 | MP0004185_abnormal_adipocyte_glucose | 0.84995840 |
| 56 | MP0000230_abnormal_systemic_arterial | 0.78941801 |
| 57 | MP0008438_abnormal_cutaneous_collagen | 0.77542604 |
| 58 | MP0000767_abnormal_smooth_muscle | 0.76657000 |
| 59 | MP0005266_abnormal_metabolism | 0.75541309 |
| 60 | MP0001879_abnormal_lymphatic_vessel | 0.73616502 |
| 61 | MP0009384_cardiac_valve_regurgitation | 0.70180553 |
| 62 | MP0003705_abnormal_hypodermis_morpholog | 0.64844622 |
| 63 | MP0000013_abnormal_adipose_tissue | 0.63964465 |
| 64 | MP0002971_abnormal_brown_adipose | 0.63941689 |
| 65 | MP0000003_abnormal_adipose_tissue | 0.58717890 |
| 66 | MP0004043_abnormal_pH_regulation | 0.58412282 |
| 67 | MP0005275_abnormal_skin_tensile | 0.56221643 |
| 68 | MP0002925_abnormal_cardiovascular_devel | 0.53199283 |
| 69 | MP0002909_abnormal_adrenal_gland | 0.49551063 |
| 70 | MP0004147_increased_porphyrin_level | 0.49233832 |
| 71 | MP0005187_abnormal_penis_morphology | 0.47114333 |
| 72 | MP0005451_abnormal_body_composition | 0.46246981 |
| 73 | MP0001299_abnormal_eye_distance/ | 0.46092181 |
| 74 | MP0005319_abnormal_enzyme/_coenzyme | 0.44720975 |
| 75 | MP0001784_abnormal_fluid_regulation | 0.44085197 |
| 76 | MP0001614_abnormal_blood_vessel | 0.44051145 |
| 77 | MP0003984_embryonic_growth_retardation | 0.43307841 |
| 78 | MP0009780_abnormal_chondrocyte_physiolo | 0.42445778 |
| 79 | MP0002088_abnormal_embryonic_growth/wei | 0.42346768 |
| 80 | MP0008569_lethality_at_weaning | 0.42053343 |
| 81 | MP0001984_abnormal_olfaction | 0.41785026 |
| 82 | MP0002078_abnormal_glucose_homeostasis | 0.41771348 |
| 83 | MP0008004_abnormal_stomach_pH | 0.39209986 |
| 84 | MP0005503_abnormal_tendon_morphology | 0.35912172 |
| 85 | MP0003806_abnormal_nucleotide_metabolis | 0.35802136 |
| 86 | MP0008961_abnormal_basal_metabolism | 0.34666242 |
| 87 | MP0002638_abnormal_pupillary_reflex | 0.33774656 |
| 88 | MP0005595_abnormal_vascular_smooth | 0.33099230 |
| 89 | MP0003045_fibrosis | 0.32279153 |
| 90 | MP0003948_abnormal_gas_homeostasis | 0.31558373 |
| 91 | MP0009115_abnormal_fat_cell | 0.30311856 |
| 92 | MP0005377_hearing/vestibular/ear_phenot | 0.28464669 |
| 93 | MP0003878_abnormal_ear_physiology | 0.28464669 |
| 94 | MP0001958_emphysema | 0.28210819 |
| 95 | MP0005167_abnormal_blood-brain_barrier | 0.27514181 |
| 96 | MP0005334_abnormal_fat_pad | 0.26607165 |
| 97 | MP0005535_abnormal_body_temperature | 0.25438151 |
| 98 | MP0000762_abnormal_tongue_morphology | 0.25337394 |
| 99 | MP0002133_abnormal_respiratory_system | 0.25017022 |
| 100 | MP0005388_respiratory_system_phenotype | 0.25017022 |
| 101 | MP0001542_abnormal_bone_strength | 0.23983899 |
| 102 | MP0002295_abnormal_pulmonary_circulatio | 0.23717116 |
| 103 | MP0002877_abnormal_melanocyte_morpholog | 0.23516719 |
| 104 | MP0005409_darkened_coat_color | 0.23453415 |
| 105 | MP0001727_abnormal_embryo_implantation | 0.23424472 |
| 106 | MP0005386_behavior/neurological_phenoty | 0.23419437 |
| 107 | MP0004924_abnormal_behavior | 0.23419437 |
| 108 | MP0000249_abnormal_blood_vessel | 0.23285764 |
| 109 | MP0003941_abnormal_skin_development | 0.22651362 |
| 110 | MP0005380_embryogenesis_phenotype | 0.22029793 |
| 111 | MP0001672_abnormal_embryogenesis/_devel | 0.22029793 |
| 112 | MP0005376_homeostasis/metabolism_phenot | 0.20494214 |
| 113 | MP0002933_joint_inflammation | 0.20019277 |
| 114 | MP0002896_abnormal_bone_mineralization | 0.19323273 |
| 115 | MP0003195_calcinosis | 0.17858792 |
| 116 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.16812612 |
| 117 | MP0006276_abnormal_autonomic_nervous | 0.16778427 |
| 118 | MP0003091_abnormal_cell_migration | 0.14003770 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * Sudden death (HP:0001699) | 7.54978688 |
| 2 | Ventricular tachycardia (HP:0004756) | 6.83725868 |
| 3 | Atrial fibrillation (HP:0005110) | 6.13629250 |
| 4 | Calf muscle hypertrophy (HP:0008981) | 6.01506669 |
| 5 | Primary atrial arrhythmia (HP:0001692) | 5.73595218 |
| 6 | Supraventricular tachycardia (HP:0004755) | 5.53712456 |
| 7 | Muscle fiber splitting (HP:0003555) | 5.49491613 |
| 8 | Supraventricular arrhythmia (HP:0005115) | 5.44242969 |
| 9 | Muscle hypertrophy of the lower extremities (HP:0008968) | 5.43845046 |
| 10 | Exercise-induced muscle cramps (HP:0003710) | 5.43436700 |
| 11 | Exercise-induced myalgia (HP:0003738) | 5.41454834 |
| 12 | Abnormality of the calf musculature (HP:0001430) | 5.41342052 |
| 13 | Right ventricular cardiomyopathy (HP:0011663) | 5.26413745 |
| 14 | Lipoatrophy (HP:0100578) | 5.25695271 |
| 15 | Subaortic stenosis (HP:0001682) | 4.94849416 |
| 16 | Abnormality of the left ventricular outflow tract (HP:0011103) | 4.94849416 |
| 17 | Hyporeflexia of lower limbs (HP:0002600) | 4.80329468 |
| 18 | Myoglobinuria (HP:0002913) | 4.52106870 |
| 19 | Bundle branch block (HP:0011710) | 4.48463368 |
| 20 | * Syncope (HP:0001279) | 4.47037011 |
| 21 | Dilated cardiomyopathy (HP:0001644) | 4.42870272 |
| 22 | Prolonged QT interval (HP:0001657) | 4.40929082 |
| 23 | Palpitations (HP:0001962) | 4.25457678 |
| 24 | EMG: myopathic abnormalities (HP:0003458) | 4.21532861 |
| 25 | Ventricular arrhythmia (HP:0004308) | 4.21209993 |
| 26 | Asymmetric septal hypertrophy (HP:0001670) | 3.98680053 |
| 27 | Heart block (HP:0012722) | 3.77195951 |
| 28 | Ventricular fibrillation (HP:0001663) | 3.72629593 |
| 29 | Increased connective tissue (HP:0009025) | 3.68474020 |
| 30 | Atrioventricular block (HP:0001678) | 3.67877604 |
| 31 | Ulnar deviation of the wrist (HP:0003049) | 3.64943337 |
| 32 | Abnormal atrioventricular conduction (HP:0005150) | 3.57683994 |
| 33 | Type 1 muscle fiber predominance (HP:0003803) | 3.57666329 |
| 34 | Difficulty running (HP:0009046) | 3.46133529 |
| 35 | Rimmed vacuoles (HP:0003805) | 3.43860368 |
| 36 | Rhabdomyolysis (HP:0003201) | 3.40445682 |
| 37 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 3.32516943 |
| 38 | Muscle fiber inclusion bodies (HP:0100299) | 3.19442237 |
| 39 | Calcaneovalgus deformity (HP:0001848) | 3.17963050 |
| 40 | Myotonia (HP:0002486) | 3.12882003 |
| 41 | Abnormal EKG (HP:0003115) | 3.10510084 |
| 42 | Difficulty climbing stairs (HP:0003551) | 2.96158278 |
| 43 | Popliteal pterygium (HP:0009756) | 2.91051593 |
| 44 | Fetal akinesia sequence (HP:0001989) | 2.90644745 |
| 45 | Left ventricular hypertrophy (HP:0001712) | 2.89174557 |
| 46 | Myopathic facies (HP:0002058) | 2.84341157 |
| 47 | Deformed tarsal bones (HP:0008119) | 2.81540021 |
| 48 | Nemaline bodies (HP:0003798) | 2.78930796 |
| 49 | Malignant hyperthermia (HP:0002047) | 2.77384270 |
| 50 | Hepatic necrosis (HP:0002605) | 2.76470937 |
| 51 | Hypoglycemic coma (HP:0001325) | 2.75098987 |
| 52 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.74891845 |
| 53 | Increased variability in muscle fiber diameter (HP:0003557) | 2.69592418 |
| 54 | Absent phalangeal crease (HP:0006109) | 2.69216149 |
| 55 | Aplasia of the musculature (HP:0100854) | 2.66661989 |
| 56 | Acute necrotizing encephalopathy (HP:0006965) | 2.66620071 |
| 57 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.63837284 |
| 58 | Neck muscle weakness (HP:0000467) | 2.62687189 |
| 59 | Bulbar palsy (HP:0001283) | 2.55601958 |
| 60 | Ketoacidosis (HP:0001993) | 2.53970894 |
| 61 | Palmoplantar keratoderma (HP:0000982) | 2.53439821 |
| 62 | Weak cry (HP:0001612) | 2.50890308 |
| 63 | Gowers sign (HP:0003391) | 2.47574128 |
| 64 | Frequent falls (HP:0002359) | 2.40745801 |
| 65 | Abnormality of the neuromuscular junction (HP:0003398) | 2.40252752 |
| 66 | Fatigable weakness (HP:0003473) | 2.40252752 |
| 67 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.36778691 |
| 68 | Hypoplastic ischia (HP:0003175) | 2.34632686 |
| 69 | Foot dorsiflexor weakness (HP:0009027) | 2.32926462 |
| 70 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.32412223 |
| 71 | Generalized muscle weakness (HP:0003324) | 2.32222462 |
| 72 | Type 2 muscle fiber atrophy (HP:0003554) | 2.31925128 |
| 73 | Ragged-red muscle fibers (HP:0003200) | 2.29584678 |
| 74 | Hepatocellular necrosis (HP:0001404) | 2.28312366 |
| 75 | Acute encephalopathy (HP:0006846) | 2.27252246 |
| 76 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.26891084 |
| 77 | Dicarboxylic aciduria (HP:0003215) | 2.26891084 |
| 78 | Limb-girdle muscle atrophy (HP:0003797) | 2.26718046 |
| 79 | Distal lower limb muscle weakness (HP:0009053) | 2.26229798 |
| 80 | Muscle stiffness (HP:0003552) | 2.25061174 |
| 81 | Progressive macrocephaly (HP:0004481) | 2.23201083 |
| 82 | Conjunctival hamartoma (HP:0100780) | 2.23014316 |
| 83 | Abnormality of alanine metabolism (HP:0010916) | 2.21553911 |
| 84 | Hyperalaninemia (HP:0003348) | 2.21553911 |
| 85 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.21553911 |
| 86 | Distal arthrogryposis (HP:0005684) | 2.19866901 |
| 87 | Abnormal finger flexion creases (HP:0006143) | 2.18968248 |
| 88 | Areflexia of lower limbs (HP:0002522) | 2.14414392 |
| 89 | EMG: neuropathic changes (HP:0003445) | 2.13862877 |
| 90 | Increased muscle lipid content (HP:0009058) | 2.12521557 |
| 91 | Cerebral edema (HP:0002181) | 2.11953977 |
| 92 | Mitochondrial inheritance (HP:0001427) | 2.10784239 |
| 93 | Scapular winging (HP:0003691) | 2.10416766 |
| 94 | Hypoplastic heart (HP:0001961) | 2.08586254 |
| 95 | Muscle fiber atrophy (HP:0100295) | 2.08297599 |
| 96 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.07452924 |
| 97 | Increased CSF lactate (HP:0002490) | 2.05327994 |
| 98 | Abnormality of the ischium (HP:0003174) | 2.04516411 |
| 99 | Facial diplegia (HP:0001349) | 2.04380350 |
| 100 | Respiratory insufficiency due to muscle weakness (HP:0002747) | 2.03817822 |
| 101 | Abnormality of placental membranes (HP:0011409) | 2.03231984 |
| 102 | Amniotic constriction ring (HP:0009775) | 2.03231984 |
| 103 | * Sudden cardiac death (HP:0001645) | 2.02957940 |
| 104 | Steppage gait (HP:0003376) | 2.02516614 |
| 105 | Testicular atrophy (HP:0000029) | 2.01527068 |
| 106 | Pheochromocytoma (HP:0002666) | 2.01370045 |
| 107 | Congestive heart failure (HP:0001635) | 2.00021505 |
| 108 | Distal lower limb amyotrophy (HP:0008944) | 1.98547466 |
| 109 | Broad metatarsal (HP:0001783) | 1.97973444 |
| 110 | Abnormality of the shoulder girdle musculature (HP:0001435) | 1.96568977 |
| 111 | Proximal amyotrophy (HP:0007126) | 1.93997356 |
| 112 | Abnormality of the foot musculature (HP:0001436) | 1.91867656 |
| 113 | Round ear (HP:0100830) | 1.91619985 |
| 114 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 1.91031576 |
| 115 | Lactic acidosis (HP:0003128) | 1.88827957 |
| 116 | Exercise intolerance (HP:0003546) | 1.88804818 |
| 117 | Dysmetric saccades (HP:0000641) | 1.87770167 |
| 118 | Increased intramyocellular lipid droplets (HP:0012240) | 1.87233692 |
| 119 | Respiratory failure (HP:0002878) | 1.86272402 |
| 120 | Neoplasm of the adrenal gland (HP:0100631) | 1.84967252 |
| 121 | Abnormality of the tricuspid valve (HP:0001702) | 1.84391642 |
| 122 | Muscular dystrophy (HP:0003560) | 1.83466517 |
| 123 | Hip contracture (HP:0003273) | 1.82483846 |
| 124 | Hamartoma of the eye (HP:0010568) | 1.81404129 |
| 125 | Progressive muscle weakness (HP:0003323) | 1.80428399 |
| 126 | Large for gestational age (HP:0001520) | 1.78794416 |
| 127 | Lower limb amyotrophy (HP:0007210) | 1.77620420 |
| 128 | Neuroendocrine neoplasm (HP:0100634) | 1.76893355 |
| 129 | Abnormality of the calcaneus (HP:0008364) | 1.74892943 |
| 130 | Waddling gait (HP:0002515) | 1.65625116 |
| 131 | Easy fatigability (HP:0003388) | 1.64683288 |
| 132 | Spinal rigidity (HP:0003306) | 1.52881811 |
| 133 | Limited hip movement (HP:0008800) | 1.52591982 |
| 134 | Hypoplastic left heart (HP:0004383) | 1.50571006 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TTN | 5.18327070 |
| 2 | OBSCN | 4.32121544 |
| 3 | MYLK | 3.83405782 |
| 4 | PDK4 | 3.80572033 |
| 5 | PDK3 | 3.80572033 |
| 6 | LMTK2 | 3.75118731 |
| 7 | PKN2 | 3.60614084 |
| 8 | PHKG1 | 3.55964208 |
| 9 | PHKG2 | 3.55964208 |
| 10 | DMPK | 3.22613007 |
| 11 | TRIB3 | 2.93402679 |
| 12 | STK24 | 2.73913095 |
| 13 | NEK1 | 2.40402986 |
| 14 | MUSK | 2.35475807 |
| 15 | TIE1 | 2.34351426 |
| 16 | PDK2 | 2.33812164 |
| 17 | PIK3CA | 2.11702749 |
| 18 | BCKDK | 1.85729179 |
| 19 | GRK7 | 1.69373200 |
| 20 | MARK1 | 1.65377385 |
| 21 | PINK1 | 1.64369815 |
| 22 | ILK | 1.56122015 |
| 23 | PAK3 | 1.42490465 |
| 24 | CAMK2D | 1.30366089 |
| 25 | PRKD1 | 1.27475889 |
| 26 | WNK4 | 1.24311832 |
| 27 | ROCK1 | 1.10406942 |
| 28 | CDC42BPA | 1.10015120 |
| 29 | MAPK12 | 1.05287676 |
| 30 | MAP3K7 | 1.03578222 |
| 31 | FLT3 | 1.02143702 |
| 32 | INSRR | 1.00525658 |
| 33 | TRPM7 | 0.97526863 |
| 34 | PDGFRA | 0.94372353 |
| 35 | MAP3K6 | 0.91079751 |
| 36 | ZAK | 0.90419867 |
| 37 | MAP3K5 | 0.90322307 |
| 38 | RIPK1 | 0.90179752 |
| 39 | DAPK3 | 0.90014814 |
| 40 | STK4 | 0.88776803 |
| 41 | MAPKAPK3 | 0.88149442 |
| 42 | EPHA3 | 0.83814838 |
| 43 | CAMK4 | 0.82480056 |
| 44 | PRKAA1 | 0.82457745 |
| 45 | STK38L | 0.80492532 |
| 46 | PRKAA2 | 0.78710344 |
| 47 | WNK1 | 0.77964770 |
| 48 | STK39 | 0.77566900 |
| 49 | PIK3CG | 0.74877010 |
| 50 | KDR | 0.71640129 |
| 51 | ROCK2 | 0.69762258 |
| 52 | CAMK2A | 0.68443945 |
| 53 | CCNB1 | 0.67945680 |
| 54 | CAMK2B | 0.66588236 |
| 55 | MAPK4 | 0.66456191 |
| 56 | EEF2K | 0.65467705 |
| 57 | STK38 | 0.64910855 |
| 58 | TGFBR2 | 0.62159383 |
| 59 | PTK2B | 0.59522027 |
| 60 | CAMK1 | 0.58905761 |
| 61 | MAP2K3 | 0.55067461 |
| 62 | EPHB1 | 0.54162149 |
| 63 | PKN1 | 0.54095069 |
| 64 | NEK9 | 0.53755211 |
| 65 | PRKACB | 0.49091012 |
| 66 | PTK6 | 0.44917502 |
| 67 | PDPK1 | 0.44058598 |
| 68 | MAP3K3 | 0.42978611 |
| 69 | PRKCE | 0.42488820 |
| 70 | AKT2 | 0.41086089 |
| 71 | RPS6KL1 | 0.39786571 |
| 72 | RPS6KC1 | 0.39786571 |
| 73 | PRKACA | 0.39430321 |
| 74 | PRKACG | 0.39368987 |
| 75 | PDK1 | 0.39347047 |
| 76 | DDR2 | 0.38339102 |
| 77 | KSR2 | 0.38107114 |
| 78 | RET | 0.38071748 |
| 79 | CAMK2G | 0.38033827 |
| 80 | ICK | 0.37941810 |
| 81 | LATS1 | 0.33651903 |
| 82 | SIK1 | 0.33586616 |
| 83 | RPS6KA6 | 0.31756106 |
| 84 | ERBB3 | 0.30038865 |
| 85 | MAP3K10 | 0.29305629 |
| 86 | NME2 | 0.26151951 |
| 87 | LRRK2 | 0.25448383 |
| 88 | FER | 0.25187218 |
| 89 | MAPK7 | 0.24887005 |
| 90 | MTOR | 0.24426241 |
| 91 | ITK | 0.24319831 |
| 92 | PRKCH | 0.24149409 |
| 93 | NLK | 0.23679972 |
| 94 | EPHB2 | 0.22917238 |
| 95 | LIMK1 | 0.22597634 |
| 96 | PRKG2 | 0.22437250 |
| 97 | MAP2K4 | 0.22065366 |
| 98 | PRKG1 | 0.22012198 |
| 99 | PDGFRB | 0.21997495 |
| 100 | SGK2 | 0.21295284 |
| 101 | TESK1 | 0.21273293 |
| 102 | LATS2 | 0.20925956 |
| 103 | RPS6KA1 | 0.20873746 |
| 104 | MAPK10 | 0.20345402 |
| 105 | FGFR4 | 0.20338702 |
| 106 | MARK2 | 0.20147165 |
| 107 | PRKCQ | 0.18796783 |
| 108 | JAK1 | 0.18681666 |
| 109 | PRKD3 | 0.18567540 |
| 110 | STK11 | 0.17467619 |
| 111 | RPS6KA3 | 0.16467797 |
| 112 | MAP2K1 | 0.15522671 |
| 113 | PAK6 | 0.14262226 |
| 114 | ZAP70 | 0.14136156 |
| 115 | DYRK1B | 0.13144816 |
| 116 | SGK3 | 0.12651773 |
| 117 | MOS | 0.12319722 |
| 118 | MAPK11 | 0.11795351 |
| 119 | RPS6KA2 | 0.11511961 |
| 120 | ADRBK1 | 0.11007269 |
| 121 | SGK1 | 0.10772440 |
| 122 | PAK2 | 0.10256521 |
| 123 | UHMK1 | 0.10094969 |
| 124 | PRKCA | 0.09003350 |
| 125 | MAPK9 | 0.08929254 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 6.01029234 |
| 2 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 4.23286538 |
| 3 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 4.22574805 |
| 4 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 3.98032702 |
| 5 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 3.84455103 |
| 6 | Propanoate metabolism_Homo sapiens_hsa00640 | 3.18366900 |
| 7 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.04326638 |
| 8 | Fatty acid degradation_Homo sapiens_hsa00071 | 3.02272254 |
| 9 | Parkinsons disease_Homo sapiens_hsa05012 | 2.93550745 |
| 10 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 2.80211960 |
| 11 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.79736677 |
| 12 | Carbon metabolism_Homo sapiens_hsa01200 | 2.37283397 |
| 13 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.30190314 |
| 14 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.26331966 |
| 15 | Alzheimers disease_Homo sapiens_hsa05010 | 2.17830474 |
| 16 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.96950221 |
| 17 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.85423532 |
| 18 | Huntingtons disease_Homo sapiens_hsa05016 | 1.81123535 |
| 19 | Viral myocarditis_Homo sapiens_hsa05416 | 1.75570079 |
| 20 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.72276187 |
| 21 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.45177903 |
| 22 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.38984118 |
| 23 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.37196948 |
| 24 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.14485589 |
| 25 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.14158632 |
| 26 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.09382720 |
| 27 | Insulin resistance_Homo sapiens_hsa04931 | 1.07682704 |
| 28 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.01143992 |
| 29 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.00309862 |
| 30 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.98972402 |
| 31 | Focal adhesion_Homo sapiens_hsa04510 | 0.95384239 |
| 32 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.94383083 |
| 33 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.90038729 |
| 34 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.87053437 |
| 35 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.78640927 |
| 36 | Lysine degradation_Homo sapiens_hsa00310 | 0.77099102 |
| 37 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.75373195 |
| 38 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.75250574 |
| 39 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.74648231 |
| 40 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.74088246 |
| 41 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.73583962 |
| 42 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.70394068 |
| 43 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.70023596 |
| 44 | Tight junction_Homo sapiens_hsa04530 | 0.68485756 |
| 45 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.68206594 |
| 46 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.63741239 |
| 47 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.59948624 |
| 48 | Salivary secretion_Homo sapiens_hsa04970 | 0.59026336 |
| 49 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.58603643 |
| 50 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.54374270 |
| 51 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.54081183 |
| 52 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.53654603 |
| 53 | Renin secretion_Homo sapiens_hsa04924 | 0.53328353 |
| 54 | Adherens junction_Homo sapiens_hsa04520 | 0.52190374 |
| 55 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.50785222 |
| 56 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.49537173 |
| 57 | Amoebiasis_Homo sapiens_hsa05146 | 0.46444287 |
| 58 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.45882942 |
| 59 | Morphine addiction_Homo sapiens_hsa05032 | 0.45386101 |
| 60 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.44900796 |
| 61 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.43536530 |
| 62 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.42325010 |
| 63 | GABAergic synapse_Homo sapiens_hsa04727 | 0.42101940 |
| 64 | Long-term potentiation_Homo sapiens_hsa04720 | 0.41638722 |
| 65 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.40969481 |
| 66 | Insulin secretion_Homo sapiens_hsa04911 | 0.40001095 |
| 67 | Prion diseases_Homo sapiens_hsa05020 | 0.38566896 |
| 68 | Peroxisome_Homo sapiens_hsa04146 | 0.38514789 |
| 69 | Galactose metabolism_Homo sapiens_hsa00052 | 0.37325890 |
| 70 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.36657011 |
| 71 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.36291813 |
| 72 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.34555109 |
| 73 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.33615833 |
| 74 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.33379824 |
| 75 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.32950314 |
| 76 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.30984402 |
| 77 | Melanogenesis_Homo sapiens_hsa04916 | 0.30922324 |
| 78 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.30454602 |
| 79 | Circadian entrainment_Homo sapiens_hsa04713 | 0.29696100 |
| 80 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.28309761 |
| 81 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.27936324 |
| 82 | Platelet activation_Homo sapiens_hsa04611 | 0.26778947 |
| 83 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.25326729 |
| 84 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.25299771 |
| 85 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.25095960 |
| 86 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.24746368 |
| 87 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.24518156 |
| 88 | Circadian rhythm_Homo sapiens_hsa04710 | 0.24140852 |
| 89 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.23267680 |
| 90 | Olfactory transduction_Homo sapiens_hsa04740 | 0.19793169 |
| 91 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.18461595 |
| 92 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.18024277 |
| 93 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.17929643 |
| 94 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.17634860 |
| 95 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.17628126 |
| 96 | Gap junction_Homo sapiens_hsa04540 | 0.17286401 |
| 97 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.16724828 |
| 98 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.16503201 |
| 99 | Sulfur relay system_Homo sapiens_hsa04122 | 0.16017965 |
| 100 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.15899225 |
| 101 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.14992452 |
| 102 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.14687281 |
| 103 | Metabolic pathways_Homo sapiens_hsa01100 | 0.14655178 |
| 104 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.14059990 |
| 105 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.13798235 |
| 106 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.13533438 |
| 107 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.12274528 |
| 108 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.11839852 |
| 109 | Bile secretion_Homo sapiens_hsa04976 | 0.11460461 |
| 110 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.11295252 |
| 111 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.10905894 |
| 112 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.10734622 |
| 113 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.09260943 |
| 114 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.08954275 |
| 115 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.06425173 |
| 116 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.06229760 |
| 117 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.06157066 |
| 118 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.05820001 |
| 119 | Taste transduction_Homo sapiens_hsa04742 | 0.04347431 |
| 120 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.04012054 |

